(19)
(11) EP 4 366 767 A2

(12)

(88) Date of publication A3:
05.10.2023

(43) Date of publication:
15.05.2024 Bulletin 2024/20

(21) Application number: 22838408.7

(22) Date of filing: 07.07.2022
(51) International Patent Classification (IPC): 
A61K 39/215(2006.01)
C07H 21/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 2319/35; C12P 21/02; C12Q 1/6897; C12N 2770/20022; C12N 2830/15; C12N 2740/16043; C07K 14/005; C12N 15/86; C12N 2770/20034; A61K 39/12; A61K 2039/53; C07K 2317/14; C07K 16/1003
(86) International application number:
PCT/US2022/036367
(87) International publication number:
WO 2023/283342 (12.01.2023 Gazette 2023/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.07.2021 US 202163219587 P
08.07.2021 US 202163219596 P
08.07.2021 US 202163219599 P
19.04.2022 US 202263332378 P

(71) Applicant: Temple University - Of The Commonwealth System of Higher Education
Philadelphia, PA 19122 (US)

(72) Inventor:
  • HU, Wenhui
    Cherry Hill, New Jersey 08003 (US)

(74) Representative: Leonard, Thomas Charles et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) OLIGONUCLEOTIDES AND VIRAL UNTRANSLATED REGION (UTR) FOR INCREASING EXPRESSION OF TARGET GENES AND PROTEINS